Science Has Put the End of AIDS Within Reach, But Politics Could Still Derail It-UNAIDS
By Michael Gwarisa in RIO DE JANEIRO, Brazil UNAIDS says the world now has the tools to end AIDS as a public health threat by 2030, but warned on Monday that funding cuts and political decisions are threatening to reverse decades of progress despite major scientific breakthroughs. Launching the 2026 Global AIDS Update ahead of
Read More
Zimbabwe Among Hardest Hit as New PEPFAR Data Shows Over 6,000 Children Lose HIV Treatment Support
By Michael Gwarisa Zimbabwe is among the countries hardest hit by recent disruptions to the United States President’s Emergency Plan for AIDS Relief (PEPFAR), with new data released ahead of the International AIDS Society (IAS) Conference on HIV Science (AIDS 2026) showing that more than 6,000 fewer children were receiving PEPFAR-supported HIV treatment by the
Read More
WHO Declares Hantavirus Outbreak Over After Final Contact Tests Negative
By Michael Gwarisa WHO has officially declared the recent hantavirus outbreak over after the last person known to have been exposed to the virus completed quarantine and tested negative. Announcing the development, World Health Organization Director-General Tedros Adhanom Ghebreyesus said the final identified contact linked to the outbreak had safely completed the required monitoring period.
Read More
Australia confirms suspected bird flu case in Western Australia amid global H5 outbreak – as authorities ramp up preparedness
By Sky News (reported) Australian authorities are investigating a suspected case of bird flu in Western Australia after a wild migratory bird tested positive for a possible H5 avian influenza infection, raising fresh concerns about the global spread of the virus. The detection was confirmed on Friday by Minister for Agriculture, Fisheries and Forestry Julie
Read More
“Finish What We Started”: WHO and Brazil Urge Leaders to Finalise Pandemic Agreement
By Michael Gwarisa The World Health Organization and the Government of Brazil have issued a joint appeal to global leaders, urging them to “finish what we started” by finalising the remaining piece of the WHO Pandemic Agreement, warning that the world remains dangerously exposed to the next health emergency. In an open letter addressed to
Read More
Bundibugyo Ebola outbreak in DRC and Uganda – where are the vaccines?
Published First on https://www.lshtm.ac.uk/ LSHTM Vaccine Centre Co-Director Dr Muhammed Afolabi discusses the Bundibugyo Ebola outbreak, the challenges of developing a vaccine against it and how to prepare for future outbreaks. On 17 May 2026 the World Health Organization (WHO) declared the outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda
Read More
World Health Summit Regional Meeting 2026 Opens in Nairobi with Strong Call for Action on Resilient Health Systems
Michael Gwarisa NAIROBI, Kenya — The World Health Summit Regional Meeting 2026 officially opened in Nairobi on Sunday, bringing together more than 2,000 global health leaders, policymakers, researchers, and development partners to push for stronger and more resilient health systems across Africa and beyond. The high-level gathering is being held under the theme, Reimagining Africa’s
Read More
Israeli Prime Minister Benjamin Netanyahu Has Prostate Cancer
Michael Gwarisa Israel’s Prime Minister, Benjamin Netanyau was diagnosed with early-stage prostate cancer following routine post-surgical monitoring, but doctors say treatment was successful and the lesion has completely disappeared. According to an official medical report dated April 20, 2026, the Prime Minister had previously undergone treatment on December 29, 2024, for benign enlargement of the
Read More
Low Viral Load Doesn’t Mean Zero Risk: What New Uganda Study Means for U=U
Michael Gwarisa For years, the global HIV response has rallied around a simple but powerful message: Undetectable equals Untransmittable, widely known as U=U. Backed by strong scientific evidence, the concept has transformed both HIV prevention and the lives of people living with the virus. But new findings from the Rakai HIV Cohort Study in Uganda
Read More
Manchester Institute of Biotechnology Develops Cheaper, Sustainable Method to Produce HIV Drug Lenacapavir
Michael Gwarisa Amid growing global pressure to make Lenacapavir more affordable, researchers at the Manchester Institute of Biotechnology have developed a new method that could significantly reduce the cost and improve the sustainability of manufacturing the long-acting HIV prevention drug. Supported by funding from the Gates Foundation, the scientists applied engineering biology, a rapidly advancing
Read More